52 filings
Page 3 of 3
8-K
iy7ia741b8q6ihg2c71v
11 May 21
Results of Operations and Financial Condition
7:57am
8-K
dq0khw
17 Feb 21
Royalty Pharma Reports Q4 2020 and Full-year Results
7:16am
8-K
iafz4o839g rv82rmezq
3 Feb 21
Other Events
8:22am
8-K
r9pnbraguwy z2xdiel
10 Nov 20
Royalty Pharma Reports Third Quarter 2020 Results
5:16pm
8-K
1kk1zs
5 Nov 20
Entry into a Material Definitive Agreement
4:40pm
8-K
hd6274b
2 Sep 20
Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes
5:26pm
8-K
gl4o4 0v75
19 Aug 20
Royalty Pharma Announces Launch of Senior Notes Offering
9:13am
8-K
f9pwmo 3n7
12 Aug 20
Royalty Pharma Reports Second Quarter 2020 Results
7:33am
8-K/A
m6k5pz3
3 Aug 20
Departure of Directors or Certain Officers
4:52pm
8-K
qeup8
3 Aug 20
Royalty Pharma Appoints Henry a. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
4:49pm
8-K
nkdtiwq03kgf4 2g1x
14 Jul 20
Pre-quarterly Results Communication
5:04pm
8-K
82y5ufiwbo3k87zr26
19 Jun 20
Entry into a Material Definitive Agreement
4:39pm